Abstract The Predicting Risk of Cardiovascular EVENTS (PREVENT) equations, created and endorsed by the American Heart Association, provide cardiovascular risk estimates for the general population, but have not yet been tested in multiethnic populations.
Articles by Roy Mathew
Volume 39 Issue 10
Oxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our Cookie Policy.
Revisiting sex as a biological variable in hypertension research
Summary and conclusions Concerted efforts continue to be made toward increasing SABV in experimental design, analysis, and reporting of clinical and basic science data. Evidence suggests that these efforts have improved inclusion of women in hypertension clinical trials since 2005 (178), although there remains work to be done, particularly with regard to device-based therapies (RND).
"Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the Unit" by Abdul Mannan Khan Minhas, Roy O Mathew et al.
Journal of the American College of Cardiology 10.1016/j.jacc.2024.03.368 yes Humans, Metabolic Syndrome, United States, Prevalence, Female, Male, Cardiovascular Diseases, Middle Aged, Cardio-Renal Syndrome, Adult Minhas, Abdul Mannan Khan; Mathew, Roy O; Sperling, Laurence S; et al., "Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States" (2024). Faculty and Staff Publications. 4161. https://digitalcommons.library.tmc.edu/baylor_docs/4161
Cardiovascular Disease in Diabetes and Chronic Kidney Disease
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
BMI and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in ISCHEMIA-CKD
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Proportional troponin changes and risk for outcomes with intervention strategies in non‐ST‐elevation acute coronary syndrome across kidney function
ACS acute coronary syndrome CABG coronary artery bypass grafting CAG coronary angiography CKD chronic kidney disease cTn cardiac troponin eGFR estimated glomerular filtration rate KFRT kidney failure requiring replacement therapy NSTE-ACS non-ST-elevation acute coronary syndrome PCI percutaneous coronary intervention 1 INTRODUCTION With the traditional exclusion of advanced chronic kidney disease (CKD) from randomized trials, the data on optimal management of acute coronary syndrome (ACS),...
Reducing Kidney Disease Burden in Type 2 Diabetes with SGLT2 Inhibitors: Shifting the Goalposts Upstream
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Mitigating Cardiovascular Disease Risk in Patients With Type 2 Diabetes and Chronic Kidney Disease-An Unmet Need With Promising Solutions
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Mitigating Cardiovascular Disease Risk in Patients With Type 2 Diabetes and Chronic Kidney Disease-An Unmet Need With Promising Solutions
Mitigating Cardiovascular Disease Risk in Patients With Type 2 Diabetes and Chronic Kidney Disease—An Unmet Need With Promising Solutions Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone Rajiv Agarwal, MD, MBBS, MS; Bertram Pitt, MD; Peter Rossing, MD; Stefan D. Anker, MD; Gerasimos Filippatos, MD; Luis M. Ruilope, MD; Csaba P.
Coronary Artery Disease in Chronic Kidney Disease: Need for a Heart-Kidney Team-Based Approach
Article Abstract Chronic kidney disease and coronary artery disease are co-prevalent conditions with unique epidemiological and pathophysiological features, that culminate in high rates of major adverse cardiovascular outcomes, including all-cause mortality. This review outlines a summary of the literature, and nuances pertaining to non-invasive risk assessment of this population, medical management options for coronary heart disease and coronary revascularisation.
LETTER TO THE EDITOR: Take your own temperature
I am writing this letter as a physician who practiced medicine in Odessa and Midland for over 18 years and not as the husband of Laura Mathew. In 2002, before I joined Texas Tech as Professor of Internal Medicine, I was a tenured full professor at Vanderbilt (1982-1986) and Duke (1986 to 2002). At present, I am Clinical Professor of Psychiatry and Internal Medicine at Texas Tech. I do know a thing or two about teaching institutions and health care.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Roy
Contact Roy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack